Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 24, 2015 9:34 PM ET

Healthcare Providers and Services

Company Overview of moksha8 Pharmaceuticals Inc.

Executive Profile

Simba Gill Ph.D.

Former Director, Codexis, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 4 different industries.

49--

Background

Dr. Simba Gill, Ph.D. founded moksha8 Pharmaceuticals, Inc. and served as its Chief Executive Officer and President. Dr. Gill was an Entrepreneur in Residence and Venture Partner at TPG Growth/Texas Pacific Group Growth. He was involved in several of TPG's healthcare investments in the Emerging Markets including ShangPharma and Agria. Dr. Gill served as Special Advisor of Maxygen Inc. since December 2005. He served as an Executive Officer of Roche Diagnostics GmbH. Prior ...

Corporate Headquarters

Av. Ibirapuera, 2332
São Paulo, São Paulo 04028-002

Brazil

Phone: 55 11 3041 9300
Fax: 55 11 3041 9323

Board Members Memberships

Former Director
Director
Founder

Education

MBA
INSEAD
PhD
King's College London

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Steven M. Klosk Chief Executive Officer, President and Director
Cambrex Corporation.
$550.0K
Feike Sijbesma Chairman of the Managing Board and Chief Executive Officer
Koninklijke DSM N.V.
$1.2M
Satoshi Masumura Chief Executive Officer, President, General Manager of Corporate R&D Division & EHS Headquarters and Representative Director
Takasago International Corporation
--
Peder Holk Nielsen Chief Executive Officer and President
Novozymes A/S
$9.7M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact moksha8 Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.